Crossmark

Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for atrial fibrillation in PortugalCost-effectiveness of new oral anticoagulants in Portuguese atrial fibrillation patients

Crossref DOI link: https://doi.org/10.1016/j.repce.2015.11.005

Published Print: 2015-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Costa, João

Fiorentino, Francesca

Caldeira, Daniel

Inês, Mónica

Lopes Pereira, Catarina

Pinheiro, Luís

Vaz-Carneiro, António

Borges, Margarida

Gouveia, Miguel
Funding

Funding for this research was provided by:

Bristol-Myers Squibb Farmacêutica Portuguesa

Laboratórios Pfizer Lda
License Information

Text and Data Mining valid from 2015-12-01

Version of Record valid from 2019-04-16
More Information

This article is maintained by: Elsevier

Article Title: Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for atrial fibrillation in PortugalCost-effectiveness of new oral anticoagulants in Portuguese atrial fibrillation patients

Journal Title: Revista Portuguesa de Cardiologia (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.repce.2015.11.005

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.repc.2015.07.004

Content Type: article

Copyright: Copyright © 2015 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L. All rights reserved.

Document is current

Any future updates will be listed below